Louise Sharpe1, Belinda Thewes, Phyllis Butow. 1. aSchool of Psychology, The University of Sydney, Sydney, New South Wales, Australia bDepartment of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands cPsycho-Oncology Co-operative Research Group, The University of Sydney, Sydney, New South Wales, Australia.
Abstract
PURPOSE OF REVIEW: An expert meeting in Ottawa in 2015 galvanized efforts to answer key questions relevant to the understanding and management of fear of cancer recurrence (FCR). The aim of this review is to summarize key developments. RECENT FINDINGS: A consensus on the definition of FCR has helped to further research in this area. There have been a number of theories put forward to account for the development of FCR, all of which share key components. Importantly, a number of important trials have been published that confirm both brief and more intensive interventions can successfully treat FCR. SUMMARY: The consensus definition of FCR is an important development, as is the development of treatments for FCR. There are now evidence-based options for the management of patients with clinical levels of FCR. Future research priorities include determining the optimal cut-off points for identifying clinically significant FCR, testing the major tenets of the recent theoretical formulations of FCR; and determining the relative efficacy and cost-effectiveness of different treatment approaches for managing FCR.
PURPOSE OF REVIEW: An expert meeting in Ottawa in 2015 galvanized efforts to answer key questions relevant to the understanding and management of fear of cancer recurrence (FCR). The aim of this review is to summarize key developments. RECENT FINDINGS: A consensus on the definition of FCR has helped to further research in this area. There have been a number of theories put forward to account for the development of FCR, all of which share key components. Importantly, a number of important trials have been published that confirm both brief and more intensive interventions can successfully treat FCR. SUMMARY: The consensus definition of FCR is an important development, as is the development of treatments for FCR. There are now evidence-based options for the management of patients with clinical levels of FCR. Future research priorities include determining the optimal cut-off points for identifying clinically significant FCR, testing the major tenets of the recent theoretical formulations of FCR; and determining the relative efficacy and cost-effectiveness of different treatment approaches for managing FCR.
Authors: Emily C Soriano; Amy K Otto; Stefanie T LoSavio; Christine Perndorfer; Scott D Siegel; Jean-Philippe Laurenceau Journal: Ann Behav Med Date: 2021-03-20
Authors: Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow Journal: Support Care Cancer Date: 2018-06-07 Impact factor: 3.603
Authors: Doris M Howell; Kelly Metcalfe; Shiying Kong; Joanne Stephen; Ivo A Olivotto; Nancy Baxter; Christine M Friedenreich; Ellen Warner; Mohammed Reza Akbari; Kristine McBain; Steven Narod; May Lynne Quan Journal: Breast Cancer Res Treat Date: 2022-04-24 Impact factor: 4.872
Authors: Emily C Soriano; Rosmeiry Valera; Elizabeth C Pasipanodya; Amy K Otto; Scott D Siegel; Jean-Philippe Laurenceau Journal: Ann Behav Med Date: 2019-03-01
Authors: Nina M Tauber; Mia S O'Toole; Andreas Dinkel; Jacqueline Galica; Gerry Humphris; Sophie Lebel; Christine Maheu; Gozde Ozakinci; Judith Prins; Louise Sharpe; Allan Ben Smith; Belinda Thewes; Sébastien Simard; Robert Zachariae Journal: J Clin Oncol Date: 2019-09-18 Impact factor: 44.544
Authors: Joanne Shaw; Helen Kamphuis; Louise Sharpe; Sophie Lebel; Allan Ben Smith; Nicholas Hulbert-Williams; Haryana Mary Dhillon; Phyllis Butow Journal: Front Psychol Date: 2021-02-22